Whilst the distribution of FemTech companies in Europe currently sits at 27% (in comparison to North America’s 51%), there is the potential for huge growth in the market. Our event aims to act as the catalyst for this growth in the development of solutions in this underserved area.
Our summit offered the opportunity for connection and partnership, bringing together the leaders and innovators from Europe and Israel, from large pharmaceutical companies and biotechs to start-ups, investors, and service providers, to collectively drive forward the women’s health market.